DaVita Inc. (DVA)

Market Cap	8.63B
Revenue (ttm)	11.74B
Net Income (ttm)	467.71M
Shares Out	91.30M
EPS (ttm)	5.07
PE Ratio	18.64
Forward PE	12.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	662,853
Open	96.53
Previous Close	96.30
Day's Range	94.51 - 97.20
52-Week Range	65.28 - 116.97
Beta	0.94
Analysts	Hold
Price Target	106.43 (+12.59%)
Earnings Date	Oct 27, 2023

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 70,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA

Financial Performance

In 2022, DaVita's revenue was $11.61 billion, a decrease of -0.08% compared to the previous year's $11.62 billion. Earnings were $560.40 million, a decrease of -42.73%.

Analyst Forecast

According to 7 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $106.43, which is an increase of 12.59% from the latest price.

Price Target

$106.43

(12.59% upside)

Analyst Consensus: Hold